{
    "xml": "<topic id=\"PHP5169\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/vardenafil\" basename=\"vardenafil\" title=\"VARDENAFIL\">\n<title>VARDENAFIL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_967\" namespace=\"/interactions/list-of-drug-interactions/vardenafil\">Vardenafil</xref>\n</p>\n<data name=\"vtmid\">407979001</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_398650772\" title=\"Phosphodiesterase type-5 inhibitors\">Phosphodiesterase type-5 inhibitors</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP49276\" outputclass=\"indicationsAndDose\" rev=\"1.46\" parent=\"/drugs/vardenafil\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Erectile dysfunction</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using tablets</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8239;mg (max. per dose 20&#8239;mg), to be taken approximately 25&#8211;60 minutes before sexual activity, subsequent doses adjusted according to response, onset of effect may be delayed if taken with high-fat meal; maximum 1&#8239;dose per day.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By mouth using orodispersible tablet</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8239;mg, to be taken approximately 25&#8211;60 minutes before sexual activity; maximum 10&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Erectile dysfunction (patients on alpha-blocker therapy)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using tablets</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8239;mg (max. per dose 20&#8239;mg), to be taken approximately 25&#8211;60minutes before sexual activity, subsequent doses adjusted according to response, onset of effect may be delayed if taken with high-fat meal; maximum 1&#8239;dose per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Concomitant treatment with phosphodiesterase type-5 inhibitor and an alpha-blocker can increase the risk of postural hypotension&#8212;initiate treatment with a phosphodiesterase type-5 inhibitor (at a low dose) only once the patient is stable on the alpha-blocker.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>\n<i>Levitra<tm tmtype=\"reg\"/> 10 mg orodispersible tablets</i> and <i>Levitra<tm tmtype=\"reg\"/> 10 mg film coated tablets</i> are <b>not</b> bioequivalent.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49303\" outputclass=\"contraindications\" rev=\"1.11\" parent=\"/drugs/vardenafil\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Avoid if systolic blood pressure below 90 mmHg</ph>; <ph outputclass=\"contraindication\">hereditary degenerative retinal disorders</ph>; <ph outputclass=\"contraindication\">myocardial infarction</ph>; <ph outputclass=\"contraindication\">patients in whom vasodilation or sexual activity are inadvisable</ph>; <ph outputclass=\"contraindication\">previous history of non-arteritic anterior ischaemic optic neuropathy</ph>; <ph outputclass=\"contraindication\">recent stroke</ph>; <ph outputclass=\"contraindication\">unstable angina</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49330\" outputclass=\"cautions\" rev=\"1.8\" parent=\"/drugs/vardenafil\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Active peptic ulceration</ph>; <ph outputclass=\"caution\">anatomical deformation of the penis (e.g. angulation, cavernosal fibrosis, Peyronie&#8217;s disease)</ph>; <ph outputclass=\"caution\">bleeding disorders</ph>; <ph outputclass=\"caution\">cardiovascular disease</ph>; <ph outputclass=\"caution\">elderly</ph>; <ph outputclass=\"caution\">left ventricular outflow obstruction</ph>; <ph outputclass=\"caution\">predisposition to priapism (e.g. in sickle-cell disease, multiple myeloma, or leukaemia)</ph>; <ph outputclass=\"caution\">susceptibility to prolongation of QT interval</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49273\" outputclass=\"interactions\" rev=\"1.14\" parent=\"/drugs/vardenafil\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (vardenafil)</p>\n<p>Caution with concomitant use of drugs which prolong QT interval.</p>\n<p>Avoid concomitant use of nitrates.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49259\" outputclass=\"sideEffects\" rev=\"1.15\" parent=\"/drugs/vardenafil\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Back pain</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">flushing</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">migraine</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">nasal congestion</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">visual disturbances</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Drowsiness</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">epistaxis</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">increased lacrimation</ph>; <ph outputclass=\"sideEffect\">painful red eyes</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">tachycardia</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anxiety</ph>; <ph outputclass=\"sideEffect\">facial oedema</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">hypertonia</ph>; <ph outputclass=\"sideEffect\">priapism</ph>; <ph outputclass=\"sideEffect\">raised intra-ocular pressure</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">syncope</ph>; <ph outputclass=\"sideEffect\">transient amnesia</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arrhythmia</ph>; <ph outputclass=\"sideEffect\">myocardial infarction</ph>; <ph outputclass=\"sideEffect\">non-arteritic anterior ischaemic optic neuropathy (stop drug if sudden visual impairment occurs)</ph>; <ph outputclass=\"sideEffect\">retinal vascular occlusion</ph>; <ph outputclass=\"sideEffect\">seizures</ph>; <ph outputclass=\"sideEffect\">serious cardiovascular events</ph>; <ph outputclass=\"sideEffect\">sudden hearing loss (discontinue drug and seek medical advice)</ph>; <ph outputclass=\"sideEffect\">unstable angina</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49279\" outputclass=\"hepaticImpairment\" parent=\"/drugs/vardenafil\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Initial dose 5&#8239;mg in mild to moderate impairment, increased subsequently according to response (max. 10&#8239;mg in moderate impairment).</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid in severe impairment.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Orodispersible tablets not suitable for patients with moderate hepatic impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49267\" outputclass=\"renalImpairment\" parent=\"/drugs/vardenafil\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Initial dose 5&#8239;mg if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2.</sup>\n</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Orodispersible tablets not suitable if eGFR less than 30&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59617\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.11\" parent=\"/drugs/vardenafil\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Orodispersible tablets not suitable for initiation of therapy in patients taking alpha-blockers.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48697\" outputclass=\"nationalFunding\" rev=\"1.50\" parent=\"/drugs/vardenafil\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (September 2011) that vardenafil orodispersible tablets (<i>Levitra </i>\n<tm tmtype=\"reg\"/>) are accepted for restricted use within NHS Scotland for men for whom an orodispersible tablet is an appropriate formulation.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"nonNHS\">\n<title>NHS restrictions</title>\n<sectiondiv>\n<p>\n<i>Levitra</i>\n<tm tmtype=\"reg\"/> is not prescribable under the NHS for the treatment of erectile dysfunction except in men who meet the criteria listed in part XVIIIB of the Drug Tariff (Part XIb of the Northern Ireland Drug Tariff, Part 12 of the Scottish Drug Tariff). The prescription must be endorsed 'SLS'. For more information see <i>Prices in the BNF</i>, under <i>How to use BNF publications</i>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP5169-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/vardenafil\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76603\" title=\"Tablet\" namespace=\"/drugs/vardenafil/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76611\" title=\"Orodispersible tablet\" namespace=\"/drugs/vardenafil/orodispersible-tablet\">Orodispersible tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78487\" namespace=\"/treatment-summaries/erectile-dysfunction\" title=\"Erectile dysfunction\" count=\"2\" rel=\"backlink\">Erectile dysfunction</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_967\" namespace=\"/interactions/list-of-drug-interactions/vardenafil\" title=\"Vardenafil\" count=\"1\" rel=\"link\">Vardenafil</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76603\" namespace=\"/drugs/vardenafil/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76611\" namespace=\"/drugs/vardenafil/orodispersible-tablet\" title=\"Orodispersible tablet\" count=\"1\" rel=\"link\">Orodispersible tablet</xref>\n</links>\n</topic>",
    "id": "PHP5169",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/vardenafil",
    "basename": "vardenafil",
    "title": "VARDENAFIL",
    "interactants": [
        {
            "id": "bnf_int_967",
            "label": "Vardenafil"
        }
    ],
    "vtmid": "407979001",
    "drugClassification": [
        "Phosphodiesterase type-5 inhibitors"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Erectile dysfunction",
                        "html": "Erectile dysfunction"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using orodispersible tablet"
                    ],
                    "textContent": "By mouth using orodispersible tablet",
                    "html": "By mouth using orodispersible tablet"
                },
                "adult": [
                    {
                        "textContent": "Initially 10 mg (max. per dose 20 mg), to be taken approximately 25&#8211;60 minutes before sexual activity, subsequent doses adjusted according to response, onset of effect may be delayed if taken with high-fat meal; maximum 1 dose per day.",
                        "html": "<p>Initially 10&#8239;mg (max. per dose 20&#8239;mg), to be taken approximately 25&#8211;60 minutes before sexual activity, subsequent doses adjusted according to response, onset of effect may be delayed if taken with high-fat meal; maximum 1&#8239;dose per day.</p>"
                    },
                    {
                        "textContent": "10 mg, to be taken approximately 25&#8211;60 minutes before sexual activity; maximum 10 mg per day.",
                        "html": "<p>10&#8239;mg, to be taken approximately 25&#8211;60 minutes before sexual activity; maximum 10&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Erectile dysfunction (patients on alpha-blocker therapy)",
                        "html": "Erectile dysfunction (patients on alpha-blocker therapy)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using tablets"
                    ],
                    "textContent": "By mouth using tablets",
                    "html": "By mouth using tablets"
                },
                "adult": [
                    {
                        "textContent": "Initially 5 mg (max. per dose 20 mg), to be taken approximately 25&#8211;60minutes before sexual activity, subsequent doses adjusted according to response, onset of effect may be delayed if taken with high-fat meal; maximum 1 dose per day.",
                        "html": "<p>Initially 5&#8239;mg (max. per dose 20&#8239;mg), to be taken approximately 25&#8211;60minutes before sexual activity, subsequent doses adjusted according to response, onset of effect may be delayed if taken with high-fat meal; maximum 1&#8239;dose per day.</p>"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Concomitant treatment with phosphodiesterase type-5 inhibitor and an alpha-blocker can increase the risk of postural hypotension&#8212;initiate treatment with a phosphodiesterase type-5 inhibitor (at a low dose) only once the patient is stable on the alpha-blocker.",
                "html": "<p>Concomitant treatment with phosphodiesterase type-5 inhibitor and an alpha-blocker can increase the risk of postural hypotension&#8212;initiate treatment with a phosphodiesterase type-5 inhibitor (at a low dose) only once the patient is stable on the alpha-blocker.</p>"
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Levitra 10 mg orodispersible tablets and Levitra 10 mg film coated tablets are not bioequivalent.",
                "html": "<p>\n<i>Levitra<tm tmtype=\"reg\"/> 10 mg orodispersible tablets</i> and <i>Levitra<tm tmtype=\"reg\"/> 10 mg film coated tablets</i> are <b>not</b> bioequivalent.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Avoid if systolic blood pressure below 90 mmHg",
                "html": "Avoid if systolic blood pressure below 90 mmHg"
            },
            {
                "type": "contraindications",
                "textContent": "hereditary degenerative retinal disorders",
                "html": "hereditary degenerative retinal disorders"
            },
            {
                "type": "contraindications",
                "textContent": "myocardial infarction",
                "html": "myocardial infarction"
            },
            {
                "type": "contraindications",
                "textContent": "patients in whom vasodilation or sexual activity are inadvisable",
                "html": "patients in whom vasodilation or sexual activity are inadvisable"
            },
            {
                "type": "contraindications",
                "textContent": "previous history of non-arteritic anterior ischaemic optic neuropathy",
                "html": "previous history of non-arteritic anterior ischaemic optic neuropathy"
            },
            {
                "type": "contraindications",
                "textContent": "recent stroke",
                "html": "recent stroke"
            },
            {
                "type": "contraindications",
                "textContent": "unstable angina",
                "html": "unstable angina"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Active peptic ulceration",
                "html": "Active peptic ulceration"
            },
            {
                "type": "cautions",
                "textContent": "anatomical deformation of the penis (e.g. angulation, cavernosal fibrosis, Peyronie&#8217;s disease)",
                "html": "anatomical deformation of the penis (e.g. angulation, cavernosal fibrosis, Peyronie&#8217;s disease)"
            },
            {
                "type": "cautions",
                "textContent": "bleeding disorders",
                "html": "bleeding disorders"
            },
            {
                "type": "cautions",
                "textContent": "cardiovascular disease",
                "html": "cardiovascular disease"
            },
            {
                "type": "cautions",
                "textContent": "elderly",
                "html": "elderly"
            },
            {
                "type": "cautions",
                "textContent": "left ventricular outflow obstruction",
                "html": "left ventricular outflow obstruction"
            },
            {
                "type": "cautions",
                "textContent": "predisposition to priapism (e.g. in sickle-cell disease, multiple myeloma, or leukaemia)",
                "html": "predisposition to priapism (e.g. in sickle-cell disease, multiple myeloma, or leukaemia)"
            },
            {
                "type": "cautions",
                "textContent": "susceptibility to prolongation of QT interval",
                "html": "susceptibility to prolongation of QT interval"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (vardenafil)\n\nCaution with concomitant use of drugs which prolong QT interval.\n\nAvoid concomitant use of nitrates.",
                "html": "<p>Appendix 1 (vardenafil)</p><p>Caution with concomitant use of drugs which prolong QT interval.</p><p>Avoid concomitant use of nitrates.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Back pain",
                        "html": "Back pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flushing",
                        "html": "flushing",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "migraine",
                        "html": "migraine",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nasal congestion",
                        "html": "nasal congestion",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "visual disturbances",
                        "html": "visual disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Drowsiness",
                        "html": "Drowsiness",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "epistaxis",
                        "html": "epistaxis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "increased lacrimation",
                        "html": "increased lacrimation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "painful red eyes",
                        "html": "painful red eyes",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "tachycardia",
                        "html": "tachycardia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Anxiety",
                        "html": "Anxiety",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "facial oedema",
                        "html": "facial oedema",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypertonia",
                        "html": "hypertonia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "priapism",
                        "html": "priapism",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "raised intra-ocular pressure",
                        "html": "raised intra-ocular pressure",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "syncope",
                        "html": "syncope",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "transient amnesia",
                        "html": "transient amnesia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Arrhythmia",
                        "html": "Arrhythmia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myocardial infarction",
                        "html": "myocardial infarction",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "non-arteritic anterior ischaemic optic neuropathy (stop drug if sudden visual impairment occurs)",
                        "html": "non-arteritic anterior ischaemic optic neuropathy (stop drug if sudden visual impairment occurs)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "retinal vascular occlusion",
                        "html": "retinal vascular occlusion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "seizures",
                        "html": "seizures",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "serious cardiovascular events",
                        "html": "serious cardiovascular events",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "sudden hearing loss (discontinue drug and seek medical advice)",
                        "html": "sudden hearing loss (discontinue drug and seek medical advice)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "unstable angina",
                        "html": "unstable angina",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Initial dose 5 mg in mild to moderate impairment, increased subsequently according to response (max. 10 mg in moderate impairment).",
                "html": "<p>Initial dose 5&#8239;mg in mild to moderate impairment, increased subsequently according to response (max. 10&#8239;mg in moderate impairment).</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid in severe impairment.",
                "html": "<p>Manufacturer advises avoid in severe impairment.</p>"
            },
            {
                "type": "generalInformation",
                "textContent": "Orodispersible tablets not suitable for patients with moderate hepatic impairment.",
                "html": "<p>Orodispersible tablets not suitable for patients with moderate hepatic impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Initial dose 5 mg if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Initial dose 5&#8239;mg if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2.</sup>\n</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Orodispersible tablets not suitable if eGFR less than 30 mL/minute/ 1.73 m2.",
                "html": "<p>Orodispersible tablets not suitable if eGFR less than 30&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Orodispersible tablets not suitable for initiation of therapy in patients taking alpha-blockers.",
                "html": "<p>Orodispersible tablets not suitable for initiation of therapy in patients taking alpha-blockers.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (September 2011) that vardenafil orodispersible tablets (Levitra ) are accepted for restricted use within NHS Scotland for men for whom an orodispersible tablet is an appropriate formulation.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (September 2011) that vardenafil orodispersible tablets (<i>Levitra </i> <tm tmtype=\"reg\"/>) are accepted for restricted use within NHS Scotland for men for whom an orodispersible tablet is an appropriate formulation.</p>"
            }
        ],
        "nonNHS": [
            {
                "type": "nonNHS",
                "textContent": "Levitra is not prescribable under the NHS for the treatment of erectile dysfunction except in men who meet the criteria listed in part XVIIIB of the Drug Tariff (Part XIb of the Northern Ireland Drug Tariff, Part 12 of the Scottish Drug Tariff). The prescription must be endorsed 'SLS'. For more information see Prices in the BNF, under How to use BNF publications.",
                "html": "<p>\n<i>Levitra</i>\n<tm tmtype=\"reg\"/> is not prescribable under the NHS for the treatment of erectile dysfunction except in men who meet the criteria listed in part XVIIIB of the Drug Tariff (Part XIb of the Northern Ireland Drug Tariff, Part 12 of the Scottish Drug Tariff). The prescription must be endorsed 'SLS'. For more information see <i>Prices in the BNF</i>, under <i>How to use BNF publications</i>.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76603",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76611",
                "label": "Orodispersible tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78487",
                "label": "Erectile dysfunction",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_967",
                "label": "Vardenafil",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76603",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76611",
                "label": "Orodispersible tablet",
                "type": "medicinalForm"
            }
        ]
    }
}